These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells. Lee MH; Lee WH; Todorov I; Liu CP J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483 [TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine. Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540 [TBL] [Abstract][Full Text] [Related]
6. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
7. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice. Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021 [TBL] [Abstract][Full Text] [Related]
8. Immune cell trafficking to the islets during type 1 diabetes. Sandor AM; Jacobelli J; Friedman RS Clin Exp Immunol; 2019 Dec; 198(3):314-325. PubMed ID: 31343073 [TBL] [Abstract][Full Text] [Related]
9. CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice. Shan Z; Xu B; Mikulowska-Mennis A; Michie SA Immunol Res; 2014 May; 58(2-3):351-7. PubMed ID: 24687731 [TBL] [Abstract][Full Text] [Related]
10. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule. Christen U; Kimmel R Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of TCR junctional variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T cell foci within the same pancreas. Sarukhan A; Bedossa P; Garchon HJ; Bach JF; Carnaud C Int Immunol; 1995 Jan; 7(1):139-46. PubMed ID: 7718510 [TBL] [Abstract][Full Text] [Related]
12. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes. Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009 [TBL] [Abstract][Full Text] [Related]
14. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. Giarratana N; Penna G; Amuchastegui S; Mariani R; Daniel KC; Adorini L J Immunol; 2004 Aug; 173(4):2280-7. PubMed ID: 15294940 [TBL] [Abstract][Full Text] [Related]
15. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Hu C; Ding H; Li Y; Pearson JA; Zhang X; Flavell RA; Wong FS; Wen L Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11318-23. PubMed ID: 26305961 [TBL] [Abstract][Full Text] [Related]
16. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway. Gurlo T; Kawamura K; von Grafenstein H J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161 [TBL] [Abstract][Full Text] [Related]
18. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066 [TBL] [Abstract][Full Text] [Related]
19. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
20. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]